2015 Rayno Biopharmaceutical Stock Portfolio
The Biotech Bull Market Is Now in its Sixth Year Led By Biopharmaceuticals
Here is the current Rayno Biopharmaceutical Stock Portfolio as of 7/13 prices:
- Top winners since inception (2009) are: Regeneron (REGN), Alexion (ALXN) and Biogen (BIIB).
- Winners 2015 YTD are Fibrocell Sciences (FCSC) up 109%, Seattle Genetics (SGEN) up 47.7%, Celldex Therapeutics (CLDX) up 35.5%, Regeneron (REGN) up 30.7% and Gilead Sciences (GILD) up 21.5%.
- Six companies were acquired over five years: Astex, Cephalon, Cubist (CBST), Optimer (OPTR), Pharmacyclics (PCYC), and Viropharma (VPHM).
- See previous posts on the Biotech Bull Market.
- Mid Cap biotechs should lead the market higher.
- All market trends in biotech are intact with healthcare sector leadership, M&A and revenue growth.
We will update the Rayno Diagnostics and Tools portfolios later this month. Top picks are Abaxis (ABAX), Cepheid (CPHD) and Illumina (ILMN).
Company | Ticker | Original Start | Price $ | 5 Yr High | RaynoTotal | Price 7/13 | YTD | |
% Perform | % Perform | |||||||
Abbvie | ABBV | 3/25/2014 | 51.7 | 70.76 | 34.8 | 69.59 | 6.31 | |
Achillion | ACHN | 3/4/2013 | 8.6 | 16.87 | 5.6 | 9.08 | -25.88 | |
Alexion | ALXN* | 2/2/2009 | 17.5 | 203.3 | 1070 | 199.11 | 7.61 | |
Alkermes | ALKS | 3/22/2013 | 23 | 75.17 | 74 | 65.05 | 11 | |
Albany Molec | AMRI | 2/10/2011 | 4.32 | 23.95 | 355 | 19.65 | 20.7 | |
Amgen | AMGN | 2/2/2009 | 55 | 173.6 | 183 | 155.76 | -2.22 | |
Array | ARRY | 5/26/2015 | 7.7 | 8.59 | -9 | 6.97 | 47.36 | |
Biogen | BIIB | 2/2/2009 | 48.5 | 480.18 | 705 | 391.23 | 15.25 | |
Celldex | CLDX | 8/20/2014 | 15 | 32.82 | 64.8 | 24.73 | 35.5 | |
Fibrocell Sci | FCSC | 6/11/2014 | 3.7 | 6.4 | 46.2 | 5.41 | 108.9 | |
Gilead Sciences | GILD* | 2/2/2009 | 25.5 | 123.37 | 347 | 114.55 | 21.5 | |
Regeneron | REGN | 2/2/2009 | 17.5 | 544 | 2965 | 536.21 | 30.7 | |
Roche ADR | RHHBY* | 1/30/2014 | 33.5 | 38.54 | 9.4 | 36.68 | 7.9 | |
Seattle Gene | SGEN | 2/2/2009 | 9.5 | 49.84 | 400 | 47.47 | 47.7 | |
Vertex | VRTX | 11/15/2013 | 62.8 | 137.5 | 97 | 124.24 | 4.58 | |
*split | ||||||||
Acquired | Acq Price | % Return | ||||||
Astex | ASTX | 1.63 | 8.5 | 421 | ||||
Cephalon | CEPH | 76.5 | 81.5 | 6.5 | ||||
Cubist | CBST | 21.5 | 102 | 374 | ||||
Optimer | OPTR | 11.8 | 10.75 | -9 | ||||
PharmCyclics | PCYC | 38.2 | 261 | 583 | ||||
ViroPharma | VPHM | 12 | 50 | 316 | ||||
Perform | ||||||||
ETFs | P 7/13 | % YTD | ||||||
FBT | 128.42 | 125 | 22.7 | |||||
IBB | 385.02 | 379 | 25 | |||||
XBI | 261.6 | 259 | 39 |
Disclosure: None.